IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/fine chemicals roundup—26 November 2013

5:35 AM MST | November 26, 2013 | Deepti Ramesh

Johnson Matthey’s fine chemicals division reports rise in sales The fine chemicals division of Johnson Matthey (London), which comprises the company's active pharmaceutical ingredient (API) manufacturing business, the catalysis and chiral technologies business, and research chemicals, generated revenue of £185 million ($298 million), in its fiscal first half ended 30 September 2013, up 8% year-on-year (YOY). Sales from the division’s API-manufacturing business increased by 7%, to £105 million.  Sales in the research chemicals business...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa